mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-07 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |